- $10.02bn
- $9.97bn
- $4.89bn
- 96
- 54
- 66
- 84
Annual balance sheet for Amdocs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 472 | 984 | 966 | 818 | 743 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 988 | 919 | 921 | 1,004 | 989 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,676 | 2,075 | 2,067 | 2,003 | 1,912 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 525 | 903 | 932 | 971 | 952 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,293 | 6,342 | 6,512 | 6,390 | 6,426 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,208 | 1,216 | 1,304 | 1,253 | 1,353 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,793 | 2,719 | 2,919 | 2,873 | 2,902 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,500 | 3,623 | 3,593 | 3,518 | 3,524 |
| Total Liabilities & Shareholders' Equity | 5,293 | 6,342 | 6,512 | 6,390 | 6,426 |
| Total Common Shares Outstanding |